Regulus Therapeutics Inc (NASDAQ:RGLS)

18.52
Delayed Data
As of Feb 27
 -0.78 / -4.04%
Today’s Change
5.40
Today|||52-Week Range
25.60
+15.46%
Year-to-Date

Today’s Trading

Previous close19.30
Today’s open19.18
Day’s range18.22 - 19.49
Volume323,922
Average volume (3 months)710,496
Market cap$935.6M
Dividend yield--
Data as of 3:59pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)-163.27%
Earnings growth (this year)+19.68%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.81%
P/E ratioNM
Price/Sales92.22
Price/Book6.87

Competitors

 Today’s
change
Today’s
% change
INSMInsmed Inc+0.38+2.09%
KPTIKaryopharm Therapeut...-0.70-2.50%
ALDRAlder Biopharmaceuti...-0.86-3.10%
SGNTSagent Pharmaceutica...-1.16-4.09%
Data as of 3:59pm ET, 02/27/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$7.7M
Annual profit (last year)-$56.7M
Net profit margin-739.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, Director &
CAO
Kleanthis G. Xanthopoulos
Chief Scientific Officer
Neil W. Gibson
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account